Thu. Mar 26, 2020 4:15 PM - 6:15 PM [Room D] Room D (1F)

Organizers: Yasumasa Iwatani (Clinical Research Center, National Hosp Organization Nagoya Medical Center), Hirokazu Tamamura (Inst Biomat Bioeng, Tokyo Med Dent Univ), Shogo Misumi (Global Cent Nat Res Sci, Kumamoto Univ)

Recent research & development (R&D) based on novel concepts and multidisciplinary pharmaceutical information have brought new effective therapeutic drugs for virus infection. For example, the mechanistic concept of new anti-HIV integrase inhibitors, which has greatly improved the prognosis of HIV-infected people, was applied to development of the new anti-influenza virus drug as a "chelate" drug. Thus, there has been a great focus on multidisciplinary R&D beyond a virus target, utilizing such novel mechanistic concepts. Here, in this session, five scientists present their unique studies on novel antiviral drugs of which the concepts are highly applicable across the fields: 1) a new strategy against membrane fusion upon HIV infection, 2) anti-influenza virus drug, Baloxavir, 3) anti-HIV RNaseH inhibitor, 4) new compound targets against Kaposi's sarcoma-associated herpesvirus infection, 5) latency-reversing agents for a new HIV-cure approach. With maximized utilization of their unique concepts, the presentations will aid us for further development of novel therapeutic drugs for virus infection as well as other diseases that is not related to virus infection.